KNG1 and Alzheimer disease: In addition, activation of the kallikrein–kinin pathway by the contact system has been evidenced by studies showing that the plasma levels of FXIIa, cHK, bradykinin, and of kallikrein activity are elevated in AD patients, correlating with the severity of cognitive decline [13,95,98].